Pericapsular nerve group block versus intrathecal morphine in hip arthroplasty: a non-blinded randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON22351

Enrollment

Registered

2020-10-06

Start date

2021-03-08

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elective hip arthroplasty

Interventions

1. Low dose intrathecal morphine via spinal anaesthesia, 2. pericapsular nerve group block with spinal anaesthesia

Eligibility

Inclusion criteria

Inclusion criteria: All hip arthroplasty patients for surgery at Noarlunga Hospital or Flinders Medical Centre with no contraindication to either spinal anaesthesia with intrathecal morphine or ropivicaine based regional technique

Exclusion criteria

Exclusion criteria: Contraindication to spinal anaesthesia. Patient refusal, allergy or contraindication to intrathecal morphine or regional analgesia

Design outcomes

Primary

Measure	Time frame
Pain score reduction	—

Secondary

Measure	Time frame
PONV, pruritis, patient satisfaction, time to mobilisation, length of stay, incidence of complications, possibly patient related outcomes measures.	—

Contacts

Public ContactD-Yin Lin

AMC (Supervised by AMC Professor Ruurd Jaarsma)

indysama@gmail.com0434001819

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)